Special Access Program for drugs: Guidance document for industry and practitioners (English, HTML)

View metadata and access the original English HTML file: Special Access Program for drugs: Guidance document for industry and practitioners.

Format

HTML

Access

file-only

Publisher-reported update

2023-12-29

This guidance document explains the regulatory information requirements and conditions for practitioners and manufacturers when drugs are requested through the Special Access Program (SAP). It explains SAP's mandate, intent and scope, and outlines the responsibilities of practitioners and manufacturers.

Access original file